ReviewCytokine effects on the basal ganglia and dopamine function: The subcortical source of inflammatory malaise

Data suggest that cytokines released during the inflammatory response target subcortical structures including the basal ganglia as well as dopamine function to acutely induce behavioral changes that support fighting infection and wound healing. However, chronic inflammation and exposure to inflammatory cytokines appears to lead to persisting alterations in the basal ganglia and dopamine function reflected by anhedonia, fatigue, and psychomotor slowing. Moreover, reduced neural responses to hedonic reward, decreased dopamine metabolites in the cerebrospinal fluid and increased presynaptic dopamine uptake and decreased turnover have been described. This multiplicity of changes in the basal ganglia and dopamine function suggest fundamental effects of inflammatory cytokines on dopamine synthesis, packaging, release and/or reuptake, which may sabotage and circumvent the efficacy of current treatment approaches. Thus, examination of the mechanisms by which cytokines alter the basal ganglia and dopamine function will yield novel insights into the treatment of cytokine-induced behavioral changes and inflammatory malaise.

Highlights► Cytokines released during inflammation target the basal ganglia and dopamine. ► Cytokines can disrupt dopamine function by effects on synthesis, packaging, release, and reuptake. ► Cytokine effects on basal ganglia dopamine may cause anhedonia, fatigue, and psychomotor slowing. ► Cytokines may contribute to behavioral disorders associated with chronic inflammation.